These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23761914)
1. Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil. Kira J J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):246. PubMed ID: 23761914 [No Abstract] [Full Text] [Related]
3. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis. Ahrens N; Salama A; Haas J J Neurol; 2001 Aug; 248(8):713-4. PubMed ID: 11569905 [No Abstract] [Full Text] [Related]
4. Role of immunosuppressive therapy for the treatment of multiple sclerosis. Stankiewicz JM; Kolb H; Karni A; Weiner HL Neurotherapeutics; 2013 Jan; 10(1):77-88. PubMed ID: 23271506 [TBL] [Abstract][Full Text] [Related]
5. Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis. Davies SL; Moral MA Drug News Perspect; 2006 Dec; 19(10):632-3. PubMed ID: 17299605 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. Michel L; Vukusic S; De Seze J; Ducray F; Ongagna JC; Lefrère F; Jacq-Foucher M; Confavreux C; Wiertlewski S; Laplaud DA J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):279-83. PubMed ID: 23704316 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for primary biliary cirrhosis and sclerosis cholangitis? Altschuler EL Nephrol Dial Transplant; 1999 Mar; 14(3):798-9. PubMed ID: 10193850 [No Abstract] [Full Text] [Related]
8. Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. Herrick AL; Lunt M; Silman AJ; Denton CP Rheumatology (Oxford); 2010 Aug; 49(8):1607-8; author reply 1608. PubMed ID: 20427293 [No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil in the treatment of multiple sclerosis: a preliminary report. Pandit L; Mustafa S; Malli C; D'Cunha A Neurol India; 2014; 62(6):646-8. PubMed ID: 25591678 [TBL] [Abstract][Full Text] [Related]
10. [Mycophenolate mofetil, a possible new immunosuppresant]. Weberová J; Voboril R; Semecký V Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919 [TBL] [Abstract][Full Text] [Related]
11. Emerging treatments in multiple sclerosis: azathioprine and mofetil. Confavreux C; Moreau T Mult Scler; 1996 Jul; 1(6):379-84. PubMed ID: 9345422 [TBL] [Abstract][Full Text] [Related]
12. Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy. Behrbohm J; Neid M; Stölzel U; Wittekind C; Hauss JP; Tillmann HL Transpl Int; 2007 Dec; 20(12):1077-9. PubMed ID: 17937765 [No Abstract] [Full Text] [Related]
13. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil. Mogyorósi A; Lippman HR; Feldman GM Am J Nephrol; 2002; 22(5-6):569-72. PubMed ID: 12381961 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil. Bell J; Ross K ANNA J; 1996 Aug; 23(4):409-10, 413. PubMed ID: 8900688 [No Abstract] [Full Text] [Related]
15. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Karassa FB; Isenberg DA N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799 [No Abstract] [Full Text] [Related]